Pharmstandard International’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q3 | $3.67M | Hold |
565,063
| – | – | 12.65% | 4 |
|
2018
Q2 | $4.33M | Sell |
565,063
-97,000
| -15% | -$743K | 17.36% | 3 |
|
2018
Q1 | $14.8M | Hold |
662,063
| – | – | 37.17% | 1 |
|
2017
Q4 | $8.44K | Hold |
662,063
| – | – | 8.68% | 4 |
|
2017
Q3 | $10.3M | Hold |
662,063
| – | – | 30.07% | 2 |
|
2017
Q2 | $9.29M | Hold |
662,063
| – | – | 32.21% | 2 |
|
2017
Q1 | $14.6M | Buy |
+662,063
| New | +$14.6M | 38.85% | 1 |
|